Timothy Lee Turner

Timothy Lee Turner

Auto-generated profile, based on publicly available information

Timothy Lee Turner

Department of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, Illinois

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
TTTimothy L. Turner
Timothy L. Turner
VNVictoria H. Nguyen
Victoria H. Nguyen
Craig C. McLauchlanCraig C. McLauchlan
Craig C. McLauchlan
ZDZaneta Dymon
Zaneta Dymon
BDBenjamin M. Dorsey
Benjamin M. Dorsey
MJMarjorie A. Jones
Marjorie A. Jones

6 June 2015 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
TTTimothy L. Turner
Timothy L. Turner
GZGuo-Chang Zhang
Guo-Chang Zhang
Soo Rin KimSoo Rin Kim
Soo Rin Kim
VSVijay Subramaniam
Vijay Subramaniam
DSDavid Steffen
David Steffen
YJYong-Su Jin
Yong-Su Jin

31 May 2016 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
GZGuo‐Chang Zhang
Guo‐Chang Zhang
IKIn Iok Kong
In Iok Kong
NWNa Wei
Na Wei
DPDairong Peng
Dairong Peng
TTTimothy L. Turner
Timothy L. Turner
YJYong-Su Jin
Yong-Su Jin

1 November 2016 in Journal of Industrial Microbiology and Biotechnology
Verified
Journal Article
Open access
PDF file
YCYoung-Wook Chin
Young-Wook Chin
WKWoo-Kyung Kang
Woo-Kyung Kang
HJHae Won Jang
Hae Won Jang
TTTimothy L Turner
Timothy L Turner
HKHyo Jin Kim
Hyo Jin Kim
Enormous advances in genome editing technology have been achieved in recent decades. Among newly born genome editing technologies, CRISPR/Cas9 is considered revolutionary because it is easy to use and highly precise for editing genes in target organisms. CRISPR/Cas9 technology has also been applied for removing unfavorable target genes. In this study, we used CRISPR/Cas9 technology to reduce ethyl carbamate (EC), a potential carcinogen, which was formed during the ethanol fermentation process by yeast. Because the yeast CAR1 gene encoding arginase is the key gene to form ethyl carbamate, we inactivated the yeast CAR1 gene by the complete deletion of the gene or the introduction of a nonsense mutation in the CAR1 locus using CRISPR/Cas9 technology. The engineered yeast strain showed a 98 % decrease in specific activity of arginase while displaying a comparable ethanol fermentation performance. In addition, the CAR1-inactivated mutants showed reduced formation of EC and urea, as compared to the parental yeast strain. Importantly, CRISPR/Cas9 technology enabled generation of a CAR1-inactivated yeast strains without leaving remnants of heterologous genes from a vector, suggesting that the engineered yeast by CRISPR/Cas9 technology might sidestep GMO regulation.

1 January 2017 in Journal of Dairy Science
Verified
Journal Article
Closed access
TTTimothy L. Turner
Timothy L. Turner
EKEunbee Kim
Eunbee Kim
CHChangHoon Hwang
ChangHoon Hwang
GZGuo-Chang Zhang
Guo-Chang Zhang
JLJing-Jing Liu
Jing-Jing Liu
YJYong-Su Jin
Yong-Su Jin
Lactose is often considered an unwanted and wasted byproduct, particularly lactose trapped in acid whey from yogurt production. But using specialized microbial fermentation, the surplus wasted acid whey could be converted into value-added chemicals. The baker's yeast Saccharomyces cerevisiae, which is commonly used for industrial fermentation, cannot natively ferment lactose. The present study describes how an engineered S. cerevisiae yeast was constructed to produce lactic acid from purified lactose, whey, or dairy milk. Lactic acid is an excellent proof-of-concept chemical to produce from lactose, because lactic acid has many food, pharmaceutical, and industrial uses, and over 250,000 t are produced for industrial use annually. To ferment the milk sugar lactose, a cellodextrin transporter (CDT-1, which also transports lactose) and a β-glucosidase (GH1-1, which also acts as a β-galactosidase) from Neurospora crassa were expressed in a S. cerevisiae strain. A heterologous lactate dehydrogenase (encoded by ldhA) from the fungus Rhizopus oryzae was integrated into the CDT-1/GH1-1-expressing strain of S. cerevisiae. As a result, the engineered strain was able to produce lactic acid from purified lactose, whey, and store-bought milk. A lactic acid yield of 0.358g/g of lactose was achieved from whey fermentation, providing an initial proof of concept for the production of value-added chemicals from excess industrial whey using engineered yeast.

2 November 2015 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
TTTimothy L. Turner
Timothy L. Turner
GZGuo‐Chang Zhang
Guo‐Chang Zhang
EOEun Joong Oh
Eun Joong Oh
VSVijay Subramaniam
Vijay Subramaniam
AAAndrew Adiputra
Andrew Adiputra
YJYong-Su Jin
Yong-Su Jin